United States · FDA National Drug Code directory
Oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-798_38688247-8bdb-ee98-e063-6294a90a8ef6
- Product NDC
- 10135-798
- Form
- SUSPENSION
- Composition / generic term
- Oxcarbazepine
- Labeler
- Marlex Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250501
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 250 mL in 1 BOTTLE, GLASS (10135-798-41) · 10135-798-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →